PTM-001-ADC

N/A

Report date: 2023/12/01 15:52:20

Base Information

Drug NamePTM-001-ADC
Drug Alias NamePTM-001-ADC
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionCD44 antigen modulators
TargetsCD44 antigen
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPTM Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesPTM Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A